Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX: RMDA)
Egypt
· Delayed Price · Currency is EGP 3.430
0.00 (0.00%)
At close: Dec 4, 2024
RMDA Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | 287.42 | 244.86 | 245.68 | 181.09 | 112.18 | 82.39 | Upgrade
|
| Depreciation & Amortization | 80.45 | 72.88 | 65.48 | 46.18 | 56.2 | 36.25 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.14 | 0.13 | 0.72 | 0.14 | -0.01 | Upgrade
|
| Stock-Based Compensation | 15.56 | 17.77 | 17.85 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 6.87 | 3.81 | 3.64 | 0.11 | 1.8 | 1.29 | Upgrade
|
| Other Operating Activities | -65.39 | 2.42 | -8.44 | -10.39 | -34.27 | -5.09 | Upgrade
|
| Change in Accounts Receivable | 93.45 | -374.86 | -243.64 | -29.45 | -135.89 | -134.38 | Upgrade
|
| Change in Inventory | -118.04 | 30.97 | -88.59 | 47.58 | -100.76 | 58.93 | Upgrade
|
| Change in Accounts Payable | 37.37 | 16.97 | 68.59 | 31.51 | -36.53 | 24.27 | Upgrade
|
| Change in Other Net Operating Assets | -272 | -59.17 | -31.35 | -25.99 | -27.2 | -10.45 | Upgrade
|
| Operating Cash Flow | 65.64 | -44.5 | 29.35 | 241.35 | -164.32 | 53.21 | Upgrade
|
| Operating Cash Flow Growth | - | - | -87.84% | - | - | 1896.13% | Upgrade
|
| Capital Expenditures | -56.57 | -91.05 | -34.38 | -52.67 | -84.99 | -81.65 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.11 | 0.18 | 0.02 | 0.02 | 0.07 | 0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | -12.77 | -162.44 | -93.9 | -185.53 | -116.14 | -9.18 | Upgrade
|
| Investment in Securities | 118.29 | 194.68 | 167.47 | 68.06 | 48.81 | -464.92 | Upgrade
|
| Investing Cash Flow | -44.77 | -58.63 | 39.22 | -170.11 | -152.24 | -555.73 | Upgrade
|
| Short-Term Debt Issued | - | 1,421 | 1,205 | 1,172 | 1,047 | 664.77 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 12.29 | Upgrade
|
| Total Debt Issued | 1,820 | 1,421 | 1,205 | 1,172 | 1,047 | 677.06 | Upgrade
|
| Short-Term Debt Repaid | - | -1,265 | -1,121 | -1,156 | -728.92 | -603.1 | Upgrade
|
| Long-Term Debt Repaid | - | -5.74 | -27.14 | -71.19 | -41.76 | -40.43 | Upgrade
|
| Total Debt Repaid | -1,833 | -1,271 | -1,149 | -1,228 | -770.68 | -643.53 | Upgrade
|
| Net Debt Issued (Repaid) | -12.34 | 149.72 | 56.96 | -55.09 | 276.46 | 33.54 | Upgrade
|
| Issuance of Common Stock | 3.23 | 2.11 | - | - | - | 582.5 | Upgrade
|
| Repurchase of Common Stock | - | - | -65.93 | - | - | - | Upgrade
|
| Common Dividends Paid | -51.28 | -16.76 | -24.31 | -14.7 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -64.29 | Upgrade
|
| Financing Cash Flow | -60.38 | 135.07 | -33.28 | -69.79 | 276.46 | 551.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | 62.27 | 0.42 | 17.22 | -0.19 | -0.73 | 0.38 | Upgrade
|
| Net Cash Flow | 22.77 | 32.37 | 52.51 | 1.26 | -40.84 | 49.61 | Upgrade
|
| Free Cash Flow | 9.07 | -135.54 | -5.03 | 188.68 | -249.31 | -28.44 | Upgrade
|
| Free Cash Flow Margin | 0.39% | -7.05% | -0.34% | 15.14% | -25.97% | -3.18% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.09 | -0.00 | 0.12 | -0.16 | -0.02 | Upgrade
|
| Cash Interest Paid | 262.06 | 186.52 | 84.82 | 89.41 | 94.95 | 107.97 | Upgrade
|
| Cash Income Tax Paid | 66.66 | 60.69 | 44.29 | 28.91 | 29.97 | 39 | Upgrade
|
| Levered Free Cash Flow | -73.84 | -381.77 | -108.98 | -7.86 | -378.52 | -62.23 | Upgrade
|
| Unlevered Free Cash Flow | 89.55 | -262.27 | -53.32 | 49.03 | -318.11 | 3.9 | Upgrade
|
| Change in Net Working Capital | 277.33 | 378.04 | 222.29 | -69.62 | 290.07 | 77.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.